Showing results (201-210 of 330) with videos related to

Sort By:
Pageof 33
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 18, 2025
Lymphocyte-Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter AnalysisTatsuya Sakane, Toshifumi Tada, Hiroshi Tei, et al.
Ultrasound in Medicine & Biology|July 7, 2019
Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic SteatosisToshifumi Tada, Hiroko Iijima, Natsuko Kobayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 29, 2019
Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinomaMakoto Chuma, Hidenori Toyoda, Juntaro Matsuzaki, et al.
Hepatology International|June 12, 2026
Identifying a biologically high-risk subgroup of anatomically resectable hepatocellular carcinomaKazunari Tanaka, Kunihiko Tsuji, Atsushi Hiraoka, et al.
Cancer Medicine|May 26, 2019
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysisAtsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, et al.
Hepatology (Baltimore, Md.)|April 23, 2024
Ultrasound-based steatosis grading system using 2D-attenuation imaging: An individual patient data meta-analysis with external validationChristian Hobeika, Maxime Ronot, Boris Guiu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 21, 2026
The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab TherapyVan Khanh Nguyen, Kosuke Matsui, Hisashi Kosaka, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 26, 2023
Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological responseShun Ishido, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 11, 2025
Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early-Stage Viral DiseaseKazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, et al.
Investigational New Drugs|September 24, 2022
Optimal threshold of alpha-fetoprotein response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumabNobuharu Tamaki, Toshifumi Tada, Masayuki Kurosaki, et al.
Pageof 33